Britta Siegmund
#132,841
Most Influential Person Now
German gastroenterologist
Britta Siegmund's AcademicInfluence.com Rankings
Britta Siegmundphilosophy Degrees
Philosophy
#6549
World Rank
#9600
Historical Rank
Logic
#3699
World Rank
#4896
Historical Rank
Download Badge
Philosophy
Why Is Britta Siegmund Influential?
(Suggest an Edit or Addition)Britta Siegmund's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 (2020) (777)
- A guide to histomorphological evaluation of intestinal inflammation in mouse models. (2014) (511)
- The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines (2002) (491)
- Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. (2001) (449)
- A guiding map for inflammation (2017) (402)
- IL-1β-converting enzyme (caspase-1) in intestinal inflammation (2001) (379)
- Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. (2002) (359)
- The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo (2005) (317)
- Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice1 (2006) (268)
- Leptin: a pivotal mediator of intestinal inflammation in mice. (2002) (264)
- Mend Your Fences (2017) (253)
- Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans (2019) (250)
- Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production (2001) (246)
- Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry (2018) (242)
- IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. (2001) (221)
- Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 (2007) (211)
- Anti‐inflammatory activities of cAMP‐elevating agents: enhancement of IL‐10 synthesis and concurrent suppression of TNF production (1998) (206)
- Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD (2015) (200)
- European Study on Orthopaedic Status of haemophilia patients with inhibitors (2007) (199)
- Ulcerative colitis (2020) (194)
- Extracellular ATP and TNF-α Synergize in the Activation and Maturation of Human Dendritic Cells1 (2000) (191)
- Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. (2013) (189)
- Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. (1998) (172)
- Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
- Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. (2001) (151)
- Metabolism of exogenous substrates by coronary endothelial cells in culture. (1990) (145)
- Adenosine kinase inhibitor GP515 improves experimental colitis in mice. (2000) (144)
- Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice (2004) (144)
- Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs (2016) (142)
- Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study (2016) (137)
- Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases (2015) (134)
- Protection of reoxygenated cardiomyocytes against hypercontracture by inhibition of Na+/H+ exchange. (1995) (126)
- Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities. (2016) (125)
- Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014 (2014) (125)
- Lipid droplet‐dependent fatty acid metabolism controls the immune suppressive phenotype of tumor‐associated macrophages (2019) (123)
- Imbalance between interleukin‐1 agonists and antagonists: relationship to severity of inflammatory bowel disease (2004) (120)
- Ulcerative colitis. (2020) (119)
- Longevity of adult ventricular rat heart muscle cells in serum-free primary culture. (1991) (116)
- Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. (1997) (114)
- Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo. (2010) (109)
- Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell. (1994) (108)
- Innate and adaptive immunity in inflammatory bowel disease. (2011) (106)
- [Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014]. (2014) (106)
- Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice (2008) (105)
- Interleukin-18 in intestinal inflammation: friend and foe? (2010) (103)
- Celiac Disease: Role of the Epithelial Barrier (2017) (101)
- Adipose-Tissue and Intestinal Inflammation – Visceral Obesity and Creeping Fat (2014) (101)
- The Interleukin-1β-Converting Enzyme Inhibitor Pralnacasan Reduces Dextran Sulfate Sodium-Induced Murine Colitis and T Helper 1 T-Cell Activation (2004) (97)
- Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation. (2002) (97)
- S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn” (2008) (96)
- Leptin deficiency, not obesity, protects mice from Con A‐induced hepatitis (2002) (95)
- Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols (2011) (94)
- Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease (2012) (93)
- Pulmonary Inflammation Induced by Pseudomonas aeruginosa Lipopolysaccharide, Phospholipase C, and Exotoxin A: Role of Interferon Regulatory Factor 1 (2002) (93)
- Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes. (2007) (93)
- Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. (2000) (92)
- Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. (2008) (91)
- Diagnostik und Therapie des Morbus Crohn: Ergebnisse einer Evidenz-basierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zusammen mit dem Kompetenznetz Chronisch entzündliche Darmerkrankungen (2008) (90)
- Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. (1990) (88)
- Sarcolemmal integrity and metabolic competence of cardiomyocytes under anoxia-reoxygenation. (1990) (87)
- Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease. (2016) (81)
- Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity (2015) (80)
- IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor. (2012) (79)
- Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides (2016) (77)
- The role of Na+/H+ exchange in ischemia-reperfusion (1996) (77)
- Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce (2020) (74)
- Recovery of anoxic-reoxygenated cardiomyocytes from severe Ca2+ overload. (1992) (72)
- Quality of life, psychosocial strains and coping in parents of children with haemophilia (2008) (70)
- Prevention of the oxygen paradox in hypoxic-reoxygenated hearts. (1991) (70)
- [Clinical practice guideline on diagnosis and treatment of Crohn's disease]. (2008) (67)
- Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice (2008) (67)
- HDAC inhibitors in models of inflammation-related tumorigenesis. (2009) (65)
- Importance of bicarbonate transport for protection of cardiomyocytes against reoxygenation injury. (2000) (64)
- Liver Fibrosis and Metabolic Alterations in Adults with Alpha1 Antitrypsin Deficiency Caused by the Pi*ZZ Mutation. (2019) (63)
- Combined Pulse Electroporation – A Novel Strategy for Highly Efficient Transfection of Human and Mouse Cells (2010) (60)
- α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon (2014) (60)
- Mesenteric fat—control site for bacterial translocation in colitis? (2012) (60)
- Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+ T Cell Polarization in Vitro and in Vivo * (2014) (59)
- Primary brain tumours and specific serum immunoglobulin E: a case–control study nested in the European Prospective Investigation into Cancer and Nutrition cohort (2011) (59)
- Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases (2011) (58)
- Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome (2016) (57)
- Calcium and the oxygen paradox. (1993) (57)
- Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. (2018) (56)
- Adipokines and Their Role in Intestinal Inflammation (2018) (55)
- Inhibitor development and mortality in non‐severe hemophilia A (2015) (54)
- Generation and characterization of mice transgenic for human IL‐18‐binding protein isoform a (2003) (54)
- Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19) (2020) (51)
- Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study (2018) (51)
- Interferon‐α induces interleukin‐18 binding protein in chronic hepatitis C patients (2002) (50)
- Simulated ischemia increases the susceptibility of rat cardiomyocytes to hypercontracture. (1997) (50)
- The Role of Visceral Fat (2012) (49)
- Defining the role of T cell‐derived leptin in the modulation of hepatic or intestinal inflammation in mice (2005) (48)
- Histone deacetylase 5 regulates the inflammatory response of macrophages (2015) (47)
- The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. (2004) (47)
- Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway. (1998) (47)
- Development of intestinal inflammation in double IL‐10‐ and leptin‐deficient mice (2004) (46)
- Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes1 (2008) (45)
- Studying the pathophysiology of coronavirus disease 2019 - a protocol for the Berlin prospective COVID-19 patient cohort (Pa- COVID-19) (2020) (45)
- Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? (2020) (45)
- High‐resolution microbiota flow cytometry reveals dynamic colitis‐associated changes in fecal bacterial composition (2016) (44)
- Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects (2017) (44)
- What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. (2011) (43)
- The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice (2003) (42)
- Specific microbiota enhances intestinal IgA levels by inducing TGF‐β in T follicular helper cells of Peyer's patches in mice (2020) (42)
- Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. (2004) (41)
- Reduction of chronic abdominal pain in patients with inflammatory bowel disease through transcranial direct current stimulation: a randomized controlled trial (2016) (41)
- EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding: Results of a Prospective Multicenter Observational Pilot Study (2016) (41)
- Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents. (1997) (41)
- Adipokine signaling in inflammatory bowel disease. (2009) (40)
- The Epithelial Barrier and its Relationship With Mucosal Immunity in In fl ammatory Bowel Disease (2017) (39)
- Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon (2017) (39)
- Role of fat and adipokines in intestinal inflammation (2014) (39)
- Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More (2020) (39)
- Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells (2021) (38)
- Alanopine and strombine are end products of anaerobic glycolysis in the lugworm, Arenicola marina L. (Annelida, polychaeta) (1985) (38)
- Calcium and sodium control in hypoxic-reoxygenated cardiomyocytes (1993) (38)
- Importance of sodium for recovery of calcium control in reoxygenated cardiomyocytes. (1994) (38)
- Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (2021) (37)
- Frontline: Interferon regulatory factor‐1 as a protective gene in intestinal inflammation: role of TCR γ δ T cells and interleukin‐18‐binding protein (2004) (36)
- The Multifaceted Role of the Inflammasome in Inflammatory Bowel Diseases (2011) (36)
- Interleukin-7 Links T Lymphocyte and Intestinal Epithelial Cell Homeostasis (2012) (35)
- Location is important: differentiation between ileal and colonic Crohn’s disease (2021) (35)
- Intestinal Microbiota and the Innate Immune System – A Crosstalk in Crohn’s Disease Pathogenesis (2015) (34)
- Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1 (2020) (33)
- Inflammatory cell infiltration and resolution of kidney inflammation is orchestrated by the cold-shock protein Y-box binding protein-1. (2017) (33)
- Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells (2017) (33)
- Resistance of endothelial cells to anoxia-reoxygenation in isolated guinea pig hearts. (1989) (32)
- Haemoassist™– a hand‐held electronic patient diary for haemophilia home care (2009) (32)
- Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner (2016) (32)
- HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation (2019) (31)
- Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS) (2019) (31)
- S2k Leitlinie Autoimmune Lebererkrankungen (2017) (31)
- CapsoCam SV-1 Versus PillCam SB 3 in the Detection of Obscure Gastrointestinal Bleeding: Results of a Prospective Randomized Comparative Multicenter Study (2019) (30)
- Role of visceral fat in colonic inflammation: from Crohn's disease to diverticulitis (2017) (30)
- Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function (2019) (29)
- Protective Effect of HOE642, a Selective Blocker of Na+‐H+ Exchange, Against the Development of Rigor Contracture in Rat Ventricular Myocytes (2000) (29)
- Bacterial Translocation – Impact on the Adipocyte Compartment (2013) (29)
- Substrate oxidation by adult cardiomyocytes in long-term primary culture. (1989) (29)
- Pralnacasan (vertex pharmaceuticals). (2003) (28)
- Mesenteric fat in Crohn's disease: the hot spot of inflammation? (2011) (28)
- Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis (2001) (27)
- FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors (2015) (27)
- Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8 (2017) (27)
- Fatty acids are not an important fuel for coronary microvascular endothelial cells (2004) (27)
- Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn’s and Colitis Organization (2020) (27)
- The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. (2011) (26)
- IκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection (2015) (26)
- Cytomegalovirus infection associated with inflammatory bowel disease. (2017) (26)
- Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis (2019) (26)
- [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review]. (2016) (26)
- The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models (2017) (24)
- T-cell Composition in Ileal and Colonic Creeping Fat – Separating Ileal from Colonic Crohn’s Disease (2018) (24)
- Manifestation of spontaneous and early autoimmune gastritis in CCR7-deficient mice. (2011) (24)
- Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE) (2018) (24)
- Targeted Therapies in Inflammatory Bowel Disease (2009) (24)
- T-cell repertoires in refractory coeliac disease (2017) (23)
- Use of a nutrition support protocol to increase enteral nutrition delivery in critically ill patients. (2014) (23)
- Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004 (2022) (22)
- Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients (2022) (22)
- Wild immunology assessed by multidimensional mass cytometry (2017) (22)
- Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn’s disease (2019) (22)
- Clinical aspects of inflammatory bowel disease (2009) (21)
- Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients. (2002) (21)
- Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. (2019) (21)
- Ulcerative Colitis: Current and Future Treatment Strategies (2013) (21)
- 1 I κ BNS protein mediates regulatory T cell development via induction of the Foxp 3 transcription factor (2013) (21)
- Prophylactic treatment with FEIBA of a haemophilia A patient with inhibitor: what are the costs, what are the benefits? (2005) (21)
- Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19 (2021) (20)
- Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein. (2004) (20)
- Clostridium difficile infection of the small bowel—two case reports with a literature survey (2011) (20)
- Selective gelatinase blockage ameliorates acute DSS colitis. (2011) (20)
- Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence (2017) (19)
- Pulmonary Manifestation of Crohn’s Disease Developed Under Treatment With Vedolizumab (2018) (19)
- Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection. (2011) (19)
- Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease (2016) (18)
- Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis (2020) (18)
- Characterization of Chromosomal Instability in Murine Colitis-Associated Colorectal Cancer (2011) (18)
- Aktualisierte S3-Leitlinie Colitis ulcerosa (2019) (18)
- Transcranial direct current stimulation in inflammatory bowel disease patients modifies resting-state functional connectivity: A RCT (2019) (18)
- Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis (2013) (18)
- Herpes Simplex Virus Sepsis in a Young Woman with Crohn's Disease. (2015) (17)
- Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie (2016) (17)
- The role of adipose tissue in inflammatory bowel diseases (2018) (17)
- The Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Reduce Clinical Score and TNF Expression in Experimental Colitis in Mice (2013) (17)
- An integrated taxonomy for monogenic inflammatory bowel disease. (2021) (17)
- Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer (2017) (17)
- ENaC Dysregulation Through Activation of MEK1/2 Contributes to Impaired Na+ Absorption in Lymphocytic Colitis (2016) (17)
- MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis (2016) (16)
- Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease (2021) (16)
- Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease (2018) (16)
- Metabolic recovery of isolated adult rat cardiomyocytes after energy depletion: existence of an ATP threshold? (1998) (15)
- Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease (2008) (15)
- Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab. (2020) (15)
- Parameters controlling opine formation during muscular activity and environmental hypoxia (1989) (15)
- Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis (2019) (15)
- Impact of staged surgery on quality of life in refractory ulcerative colitis (2017) (14)
- International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey (2021) (14)
- P104 Anaeroplasma, a potential anti-inflammatory probiotic for the treatment of chronic intestinal inflammation (2019) (14)
- Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2018) (14)
- Faecal microbiota transplantation-A clinical view. (2016) (13)
- Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study (2018) (13)
- Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life (2016) (13)
- International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases (2021) (13)
- Esophageal giant ulcer in primary human immunodeficiency virus infection is associated with an infiltration of activated T cells (2007) (13)
- PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study (2021) (12)
- Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon (2017) (12)
- Co‐morbidities and bleeding in elderly patients with haemophilia—A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH) (2017) (12)
- Is intensity the solution for FMT in ulcerative colitis? (2017) (12)
- Exploring & exploiting our 'other self' - does the microbiota hold the key to the future therapy in Crohn's? (2014) (12)
- Architectural and functional alterations of the small intestinal mucosa in classical Whipple’s disease (2017) (11)
- Celiac Disease Monocytes Induce a Barrier Defect in Intestinal Epithelial Cells (2019) (11)
- Ulcerative Colitis (2016) (11)
- Complement and Neutrophil Function Changes After Liver Resection in Humans (2009) (11)
- COVID-19—from mucosal immunology to IBD patients (2021) (10)
- Inflammatory Bowel Disease Clinical (2015) (10)
- [Short version of the updated German S3 (level 3) guideline on diagnosis and treatment of Crohn's disease]. (2008) (10)
- High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders (2018) (10)
- Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn’s Disease and Regulated By Microbial and Inflammatory Signaling (2020) (10)
- Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors (2017) (10)
- Myocardial protection during reperfusion. (1996) (10)
- Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn’s disease and ulcerative colitis (2019) (9)
- The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study (2020) (9)
- CCR7 deficiency causes diarrhea associated with altered ion transport in colonocytes in the absence of overt colitis (2012) (9)
- Bone marrow Th17 TNFα cells induce osteoclast differentiation and link bone destruction to IBD (2014) (9)
- Inhibitor-Immunology-Study (2008) (8)
- Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes (2007) (8)
- Prevention of the oxygen paradox in the isolated cardiomyocyte and the whole heart. (1992) (8)
- Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) (8)
- Vedolizumab bei Colitis ulcerosa und Morbus Crohn: eine Standortbestimmung (2015) (8)
- DOP044 Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence (2014) (8)
- Neutralization of IL-18 exerts anti-inflammatory activity in experimental colitis in mice* (2001) (7)
- Changes in the energy metabolism of cultured lens epithelial cells in comparison with the fresh lens. (1990) (7)
- Feasibility of Intestinal MR Elastography in Inflammatory Bowel Disease (2021) (7)
- Targeting human CD2 by the monoclonal antibody CB.219 reduces intestinal inflammation in a humanized transfer colitis model. (2015) (7)
- Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms (2018) (7)
- P617 Extraintestinal autoimmune phenomena during treatment with vedolizumab. (2017) (7)
- Molecular basis of histone deacetylase inhibitors as new drugs for the treatment of inflammatory diseases and cancer. (2009) (7)
- Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome (2021) (7)
- Need for Prophylactic Treatment in Adult Haemophilia A Patients (2009) (7)
- [August 2019 - AWMF-Registriernummer: 021-009]. (2019) (7)
- Extraluminal factors contributing to inflammatory bowel disease. (2011) (7)
- [Current position on Vedolizumab for ulcerative colitis and Crohn's disease]. (2015) (7)
- Management of Mild-to-Moderate Ulcerative Colitis (2015) (7)
- Therapy of complicated Crohn’s disease during pregnancy—an interdisciplinary challenge (2014) (7)
- Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis. (2004) (7)
- Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography (2021) (7)
- Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease (2020) (7)
- A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients (2022) (7)
- Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study. (2019) (7)
- Validation of the ‘United Registries for Clinical Assessment and Research’ [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease (2018) (6)
- Store‐operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease (2021) (6)
- Transitionsmedizin – strukturelle Lösungsansätze (2018) (6)
- Editorial: Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing (2018) (6)
- Untersuchungen zur Problematik der Extraktion von Aromastoffen mit der simultanen Destillation-Extraktion nach Likens-Nickerson (1996) (6)
- [Inflammatory bowel disease and pregnancy]. (2009) (6)
- Microbial Colonization in Adulthood Shapes the Intestinal Macrophage Compartment. (2019) (6)
- [Azathioprine in Crohn's disease therapy--guidance against the background of recent studies]. (2014) (6)
- Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues (2021) (6)
- Das Leitlinienprogramm der DGVS 2017 (2017) (6)
- Influence of fibrosis progression on the viscous properties of in vivo liver tissue elucidated by shear wave dispersion in multifrequency MR elastography. (2021) (6)
- A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis (2019) (6)
- Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases (2022) (6)
- Kurzfassung der aktualisierten S3-Leitlinie der DGVS und des Kompetenznetzwerkes CED zur Diagnostik und Behandlung des Morbus Crohn (2008) (6)
- [August 2019 - AWMF-Registriernummer: 021-009]. (2019) (6)
- An internet portal for the development of clinical practice guidelines (2010) (6)
- Inhibitor-Immunology-Study (2011) (5)
- Suppressor αβ T Lymphocytes Control Innate Resistance to Endotoxic Shock (2005) (5)
- Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia (2022) (5)
- Comparative effectiveness of plasma‐derived and recombinant FVIII concentrates in the on‐demand and prophylactic treatment of patients with haemophilia A (2004) (5)
- Intermittent dyspnea and cyanosis in a newborn caused by a hairy polyp. (2014) (5)
- IBD in 2017: Development of therapy for and prediction of IBD — getting personal (2018) (5)
- Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten (2020) (5)
- Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial (2021) (5)
- Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy (2021) (5)
- Aktuelle Diagnostik und Therapie des Morbus Crohn (2007) (5)
- Noduläre regenerative Hyperplasie als Nebenwirkung von Azathioprin bei Morbus Crohn Nodular regenerative hyperplasia: a side effect of azathioprine in a patient with Crohn's disease (2008) (4)
- Severe ischemic injury and the oxygen paradox (1993) (4)
- A case series in patients with enteropathy and granulomatous diseases (2015) (4)
- Reduction of intra-abdominal pain through transcranial direct current stimulation (2019) (4)
- Suppressor alphabeta T lymphocytes control innate resistance to endotoxic shock. (2005) (4)
- Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b (2015) (4)
- [Inflammatory Bowel Disease Competence Network]. (2016) (4)
- IkBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection (2015) (4)
- [Inhibitor development against FVIII in previously treated patients with haemophilia A. A retrospective data collection]. (2010) (4)
- Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology (2021) (4)
- Medical Therapy of Fibrostenotic Crohn's Disease (2015) (4)
- Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial (2023) (4)
- The use of the creatine kinase reaction to determine free energy change of ATP hydrolysis in anoxic cardiomyocytes (1989) (4)
- Extracellular Matrix Components as Diagnostic Tools in Inflammatory Bowel Disease (2021) (3)
- [Transition medicine-structural solutions]. (2018) (3)
- Reprogramming Intestinal Epithelial Cell Polarity by Interleukin-22 (2021) (3)
- [Career path in German university medicine]. (2009) (3)
- Deciphering the vedolizumab dosing conundrum in IBD: when less is more (2021) (3)
- 455 Role of MDM2 as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) (2014) (3)
- A.129 Protective mechanism of halothane on myocardial reperfusion injury (1996) (3)
- Transglutaminases: new target molecules for inflammatory bowel disease? (2005) (3)
- Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy? (2022) (3)
- Protection of isolated cardiomyocytes against reoxygenation-induced hypercontracture by SIN-1C (1998) (3)
- Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice—results of a non-representative survey (2018) (3)
- Aktualisierung der S3-Leitlinie Colitis ulcerosa 2019 (2019) (3)
- [Limits of the G-DRG system to reflect Complexity in German University Hospitals]. (2020) (3)
- Wahrnehmung der Schutzimpfung gegen die Neue Grippe H1N1 von Patienten mit Morbus Crohn oder Colitis ulcerosa (2011) (3)
- 460 RAPID INDUCTION EFFECTS OF OZANIMOD ON CLINICAL SYMPTOMS AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE INDUCTION PHASE OF TRUE NORTH (2021) (3)
- Recombinant human beta 2-defensin fusion proteins as a tool to investigate defensin structure and function in small human intestinal tissue samples (2012) (3)
- Aktualisierung der Colitis ulcerosa Leitlinie 2020 (2020) (3)
- [Clinical practice guideline on diagnosis and treatment of Crohn's disease - summary for the general practitioner]. (2009) (3)
- Die Stellung von Leptin im Immunsystem : Verbindung von Endokrinologie und Immunologie (2005) (3)
- Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis (2019) (3)
- [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease]. (2008) (3)
- Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease. (2022) (3)
- [Proctocolectomy in ulcerative colitis : is a multistep procedure in cases of immunosuppression advisable?]. (2013) (3)
- Pathophysiologie der Zöliakie (2015) (2)
- Confocal endomicroscopy in diagnosis of intestinal chronic graft‐versus‐host disease (2018) (2)
- Visualization of Inflammation in Experimental Colitis by Magnetic Resonance Imaging Using Very Small Superparamagnetic Iron Oxide Particles (2022) (2)
- P393 Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy (2020) (2)
- [Etiopathogenesis of chronic inflammatory bowel diseases. Role of the immune system]. (2014) (2)
- Early Onset of TNFα-Driven Arthritis, Auto-inflammation, and Progressive Loss of Vision in a Patient with ALPK1 Mutation (2022) (2)
- Author Correction: A guiding map for inflammation (2020) (2)
- Ätiopathogenese chronisch-entzündlicher Darmerkrankungen (2014) (2)
- Qualität in der Gastroenterologie – Bericht aus der Kommission Qualität der DGVS (2018) (2)
- Leitlinie „Diagnostik und Therapie des Morbus Crohn“ – Kurzfassung für Internisten und Hausärzte (2009) (2)
- [Cancer Surveillance in Inflammatory Bowel Diseases]. (2019) (2)
- P482 Patient and physician perspectives on the management of inflammatory bowel disease: Disease remission and durability of treatment (2020) (2)
- Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn's disease: clinical and MRI results from a prospective inception cohort. (2022) (2)
- Multiple Muskelabszesse bei tibetanischer Patientin (2000) (2)
- Su1461 Lymphocytic Colitis-Related Diarrhea Is Caused by Both, ERK1/2-Dependent Inhibition of the Epithelial Sodium Channel (ENac) and a Claudin-Induced Barrier Defect (2014) (2)
- Die Proktokolektomie bei Colitis ulcerosa (2013) (2)
- Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry (2018) (2)
- Sustained Off-Treatment Response After Discontinuation of Long-Term Nucleos(t)ide Analogue Treatment in HBeAg-Seronegative Hepatitis B: A Case Series. (2017) (2)
- Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype (2021) (2)
- New insights into intestinal secretion (2013) (2)
- P043 Small intestinal inflammation but not colitis drives pro-inflammatory nutritional antigen-specific T-cell response (2020) (2)
- Seltenen Erkrankungen auf der Spur – das Register für Refraktäre Sprue (2015) (2)
- Challenges and Opportunities in IBD Clinical Trial Design. (2021) (2)
- Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease (2018) (2)
- DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation study (2018) (2)
- Mo1334 Reasons for the Delay of Diagnosis in Inflammatory Bowel Disease (2013) (2)
- Recognition of food antigens by the mucosal and systemic immune system: Consequences for intestinal development and homeostasis. (2021) (2)
- Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations (2022) (2)
- [What has been confirmed in the treatment of inflammatory bowel disease?]. (2010) (2)
- Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis. (2021) (2)
- [When is severe haemophilia A diagnosed in children and when do they start to bleed? Re-evalution after 10 years of experience]. (2010) (2)
- [Prophylaxis in haemophilia B. Prevention of bleeds and FIX consumption]. (2010) (2)
- Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial (2022) (2)
- Mo1940 E. Coli α-Hemolysin (HlyA) Mediates Colonic Inflammation (2014) (2)
- Liver Fibrosis and Metabolic Alterations in Adults with Homozygous Alpha1-antitrypsin Deficiency (PiZZ Genotype) (2018) (1)
- Prophylaxis in haemophilia B (2010) (1)
- [Desmopressin parenteral in patients with VWD1, VWD 2A and thrombocytopathy]. (2011) (1)
- Energy Metabolism of Adult Cardiomyocytes (1988) (1)
- [Haemophilia A therapy of adults. Actual treatment situation in a haemophilia centre]. (2010) (1)
- Energy Metabolism and Hypoxic Injury of Cardiomyocytes (2019) (1)
- Preliminary Observations from the European Study on Orthopedic Status (ESOS) in Hemophilia Patients with Inhibitors. (2006) (1)
- Haemophilia A therapy of adults (2010) (1)
- Mitochondrial injury in the ischemic-reoxygenated cardiomyocyte: the role of lipids and other pathogenic factors (1995) (1)
- Chronisch-entzündliche Darmerkrankungen (2012) (1)
- Was ist gesichert in der Therapie chronisch entzündlicher Darmerkrankungen? (2010) (1)
- Aktuelle therapeutische Strategien beim Morbus Crohn (2017) (1)
- Refraktäre Zöliakie (2015) (1)
- Ustekinumab – eine Standortbestimmung (2018) (1)
- Postoperative Therapie und Remissionserhaltung bei Morbus Crohn (2014) (1)
- Aktualisierung der Colitis-ulcerosa-Leitlinie 2020 (2020) (1)
- Azathioprin in der Therapie des Morbus Crohn – eine Standortbestimmung vor dem Hintergrund aktueller Studien (2014) (1)
- P004 IL-22 affects barrier function and cell polarity by MAPK/PI3 kinase signal transduction (2019) (1)
- In vivo efficacy of the specific type 4 phosphodiesterase inhibitor mesopram in DSS-induced murine colitis (2001) (1)
- A 39-Year-Old Man With Crohn's Disease and a Unclear Rash on His Left Cheek. (2020) (1)
- [Inflammatory bowel disease: cardinal signs and their diagnostics]. (2018) (1)
- Regulation of Macrophage Phenotype in Crohn's Disease Hypertrophied Adipose Tissue (2011) (1)
- [Rare diseases on the trail--the registry for refractory sprue]. (2015) (1)
- TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability (2022) (1)
- POS0410 BIOMARKERS REFLECTING DISTURBED GUT BARRIER DIFFER IN PATIENTS WITH SPONDYLOARTHRITIS, CROHN’S DISEASE AND ACUTE ANTERIOR UVEITIS (2021) (1)
- Are Immunosuppressants Becoming Obsolete? (2016) (1)
- Functional Brain Changes Due to Chronic Abdominal Pain in Inflammatory Bowel Disease: A Case-Control Magnetic Resonance Imaging Study (2022) (1)
- Standards of medical treatment and nutrition in Crohn’s disease (2005) (1)
- Multi-center study of liver disease in alpha1-antitrypsin deficiency: non-invasive evaluation of liver fibrosis in homozygous PiZZ patients (2017) (1)
- TNF and Its Impact on Adaptive Immune Mechanisms and Chronic Inflammation (2015) (1)
- Azathioprine allows glucocorticoid withdrawal – post hoc results of a prospective study in patients with inflammatory bowel diseases (2017) (1)
- [Ustekinumab - Current position]. (2018) (1)
- Results from the German registry for refractory celiac disease (2021) (1)
- Alemtuzumab as possible alternative treatment for Refractory Celiac Disease Type II (2019) (1)
- IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: the PROCTRIAL Consensus. (2022) (1)
- Su1080 Patient Education in a 14 Month Randomized Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-Adherence (2014) (1)
- JAKs in the new treatment paradigms of IBD. (2020) (1)
- Unintentional Long-Term Esophageal Stenting due to a Complete Response in a Patient with Stage UICC IV Adenocarcinoma of the Gastroesophageal Junction (2016) (1)
- [Premedication for relaxed electroconvulsive therapy]. (1987) (1)
- P326 Efficacy of vedolizumab on patient-reported outcomes in ulcerative colitis patients: results from a prospective German observational study. (2017) (1)
- Correspondence on: ‘Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?’ by Wallman et al (2019) (1)
- Impact of Microbiota on Intestinal Immune Cell Composition and Intestinal Barrier Function (2017) (1)
- P063 HDAC as versatile regulators of the intestinal epithelial barrier in inflammatory bowel disease. (2017) (1)
- dPGS Regulates the Phenotype of Macrophages via Metabolic Switching. (2019) (1)
- Complication rates of direct puncture and pull-through techniques for percutaneous endoscopic gastrostomy: Results from a large multicenter cohort (2022) (1)
- Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model (2015) (1)
- University of Southern Denmark Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation Hamesch, (2019) (0)
- Contents Vol. 25, 2009 (2009) (0)
- Subject Index Vol. 27, 2009 (2009) (0)
- HDAC as Versatile Regulators of the Intestinal Barrier Integrity and Epithelial Regeneration in Inflammatory Bowel Disease (2017) (0)
- Su1867 Characterization of Epithelial Barrier Function in Intestinal Graft-Versus-Host Disease (2014) (0)
- P034 Disruption of the intestinal barrier through M1 macrophages relevance for IBD (2012) (0)
- Retrospektive Multicenter-Studie über die Indikationen, Komplikationen sowie das Outcome der modularen Cholangioskopie bei 250 Untersuchungen mit SpyGlassTMDS (2017) (0)
- [The role of leptin in the immune system--a linking of endocrinology and immunology]. (2005) (0)
- P014 The inflammasome induces macrophage-mediated disruption of the epithelial barrier (2013) (0)
- GUT-SELECTIVE BIOLOGIC THERAPY FOR ULCERATIVE COLITIS: LESSONS FROM SCIENCE AND PRACTICE (2015) (0)
- 458 NOVEL BUDESONIDE SUPPOSITORY AND BUDESONIDE RECTAL FOAM INDUCE MUCOSAL HEALING IN ACUTE ULCERATIVE PROCTITIS (2021) (0)
- [Chronic inflammatory bowel diseases. Clinical aspects and new therapy approaches]. (2012) (0)
- Epithelial RAC1 niches in IBD: from barrier integrity to cytoskeletal plasticity (2022) (0)
- HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation (2019) (0)
- Update M. Crohn (2009) (0)
- DOP86 An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn’s ileitis (2020) (0)
- POS1209 SUCCESSFUL TREATMENT OF SEVERE COVID-19 PNEUMONIA AND CYTOKINE RELEASE WITH SIMULTANEOUS TOCILIZUMAB AND ANAKINRA WITH ONE-MONTH FOLLOW-UP (2021) (0)
- OP0260 Lower Intestinal Perforations Are More Frequent and Present Untypically in Patients Treated with Tocilizumab Compared To Other Biologic or Conventional Synthetic DMARDS (2016) (0)
- Tu1472: RAPIDITY OF OZANIMOD-INDUCED SYMPTOMATIC RESPONSE AND REMISSION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE INDUCTION PERIOD OF TRUE NORTH (2022) (0)
- Colitis ulcerosa – Standard-therapie 2004 (2005) (0)
- P398 Leptin controls immune cell composition and activity in acquired generalised lipodystrophy with combined Crohn’s disease (2019) (0)
- Protective Effects of Epigenetic Modifications in Experimental Inflammatory Bowel Disease (2009) (0)
- Cytomegalovirus-esophagitis as initial presentation of HIV infection mimicking adenocarcinoma. (2010) (0)
- P038 Expression analysis in colitis-associated carcinoma: a role for osteopontin? (2019) (0)
- Malassimilationssyndrom (2021) (0)
- The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease. (2022) (0)
- DOP51 Investigation on the role of Par4-associated cell polarity and associated barrier defects in inflammatory bowel diseases (2020) (0)
- Prof. Dr. med. Stefan Zeuzem (2019) (0)
- Sa1667 - Profiling of RNA Expression in Colitis Associated Cancer (Cac) - A Comparative Study in IBD and Cac Patients (2018) (0)
- Uptake of Tropheryma whipplei by Intestinal Epithelia (2023) (0)
- Immunohistochemical study of AuroraB proves association with differentiation and expression of crucial progression markers in gastroenteropancreatic neuroendocrine neoplasms (2016) (0)
- ON DEMAND TREATMENT AND CONTINUOUS PROPHYLAXIS OF ADULT HAEMOPHILIA A PATIENTS: A COMPARATIVE RETROSPECTIVE DATA ASCERTAINMENT (2007) (0)
- Tu1970 Givinostat Induces an M2 Macrophage Phenotype and Modulates IL-6 Signaling (2012) (0)
- Su1823 PATIENT AND PHYSICIAN PERSPECTIVES ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: DISEASE REMISSION AND DURABILITY OF TREATMENT (2020) (0)
- P169 DEFINITION OF REMISSION IN INFLAMMATORY BOWEL DISEASE: ASSESSMENT OF PATIENT AND PHYSICIAN PERSPECTIVES (2020) (0)
- P082 Divergent effects of gut bacteria altered in dysbiosis of inflammatory bowel disease on monocytes and macrophage polarisation (2014) (0)
- P014 Disruption of epithelial barrier function by coeliac peripheral blood mononuclear cells (2019) (0)
- Aktuelle therapeutische Strategien beim Morbus Crohn (2018) (0)
- Diagnosestellung der Refraktären Zöliakie: die Rolle der fluoreszenz-aktivierten Durchflusszytometrie intestinaler Lymphozyten (2018) (0)
- [Immunobiology of chronic inflammatory bowel diseases]. (2006) (0)
- P081 The immunological role of intestinal adipose tissue in dextran sodium sulfate-induced colitis (2018) (0)
- P590 Reasons for discontinuation and switch of biologic therapy in IBD: findings from a large international observational study (03). (2017) (0)
- Recombinant human beta 2-defensin fusion proteins as a tool to investigate defensin structure and function in small human intestinal tissue samples (2012) (0)
- P055 HDAC dependent regulation of the IL-6/STAT3 pathway during T helper cell activation (2013) (0)
- Contents Vol. 27, 2009 (2009) (0)
- Sauerstofftherapie bei akuter Atemnot (2001) (0)
- Verordnung, Kosten und Rechtslage (2001) (0)
- Letter to the Editor. (2022) (0)
- Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response (2021) (0)
- P008 Store-operated calcium entry controls immune cell function and activation in Inflammatory Bowel Disease (2021) (0)
- Belastungshypoxie und nächtliche Hypoxämie (2001) (0)
- Problem der Hyperkapnie (2001) (0)
- Ursachen und Folgen der chronischen Hypoxämie (2001) (0)
- Eigenschaften verschiedener Sauerstoffquellen (2001) (0)
- Mustertexte zur Verordnung von Sauerstoff (2001) (0)
- Indikationen zur Sauerstofflangzeittherapie (2001) (0)
- iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis (2023) (0)
- Betreuung zu Hause und im Urlaub (2001) (0)
- Early Onset of TNFα-Driven Arthritis, Auto-inflammation, and Progressive Loss of Vision in a Patient with ALPK1 Mutation (2022) (0)
- Der spezifische dual-selektive Typ–3/4 Phosphodiesterase Inhibitor Pumafentrine führt zu einer signifikanten Verbesserung der experimentellen Kolitis in der Maus (2005) (0)
- Mitteilungsseiten der DGIM (2015) (0)
- Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells (2017) (0)
- W1619 Similar Expression of Innate Receptors in Preadipocytes and Macrophages: Adipose Tissue As First Line of Defence in Intestinal Inflammation ? (2009) (0)
- Die Rolle des mesenterialen Fettgewebes in intestinalen Entzündungsreaktionen (2019) (0)
- P037 Bacterial handling defect in macrophages of patients with defects in glucose-6-phosphate metabolism and Crohn’s disease like intestinal inflammation (2018) (0)
- Molekulare Diagnostik der infektiösen Gastroenteritis (2020) (0)
- Analyse Nahrungsantigen-spezifischer T-Zellen im peripheren Blut bei CED-Patienten (2018) (0)
- Hypomotilität des Dünndarms – seltene Folge einer Sarkoidose? (2008) (0)
- F 16 – Chronische Diarrhö (2007) (0)
- P157 Reasons for a delayed diagnosis in inflammatory bowel disease (2013) (0)
- Aktualisierte S3-Leitlinie Colitis ulcerosa (2019) (0)
- Ein Sinnbild für die Gemeinschaft (2019) (0)
- Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline (2020) (0)
- Ein lokales Leptinnetzwerk moduliert die chronisch intestinale Entzündung im Mausmodell (2015) (0)
- Vorstellung des nationalen Schwangerschaftsregisters für Patientinnen mit einer chronisch entzündlichen Darmerkrankung (PRegCED) (2021) (0)
- Subjekt Index Vol. 25, 2009 (2009) (0)
- ["Choosing wisely" - mission and aims]. (2020) (0)
- Häufigkeit erblicher Merkmale bei Patienten mit Adenokarzinomen des ösophagogastralen Übergangs (AEG) und Magens (GC): Eine prospektive Studie in Berlin - finale Ergebnisse (2021) (0)
- Tu1473: RECTAL BUDESONIDE FORMULATIONS ARE WELL ACCEPTED BY PATIENTS WITH ULCERATIVE PROCTITIS AND IMPROVE WORK PRODUCTIVITY AND QUALITY OF LIFE (2022) (0)
- Pharmakologische Suppression der Synthese von Tumor-Nekrose-Faktor (2000) (0)
- P065 Effects of gut bacteria on the intestinal immune cell composition and barrier function. (2017) (0)
- [Chronic inflammatory bowel diseases: state of the art]. (2014) (0)
- Postoperative Therapie und Remissionserhaltung bei Morbus Crohn (2013) (0)
- Autoren (2021) (0)
- Chronisch entzündliche Darmerkrankungen: Leitsymptome und Diagnostik (2018) (0)
- HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells via the control of apoptosis and cellular exhaustion (2021) (0)
- Durchflusszytometrische Analyse intestinaler Lymphozyten bei Zöliakie und refraktärer Zöliakie (2016) (0)
- [Biosimilars in inflammatory bowel disease]. (2016) (0)
- Morphologie und T-Zell-Infiltration des Fettgewebes – Vergleich von Morbus Crohn und Adipositas per magna (2015) (0)
- Analyse von zirkulierenden Nahrungsantigen-spezifischen T-Zellen im peripheren Blut bei CED-Patienten (2019) (0)
- HDAC-abhängige Regulation des IL-6/STAT3 pathway bei T-Helferzellaktivierung (2013) (0)
- [Chronic inflammatory bowel diseases]. (2014) (0)
- Deutsches ESD-Register – aktueller Stand (2018) (0)
- Qualität in der Gastroenterologie – „Vorschläge der Kommission Qualität der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten zur ambulanten und stationären Qualitätssicherung“ (2021) (0)
- [Possibilities and limits in the therapy of metastatic hypernephroid carcinoma]. (1980) (0)
- Was wollen wir mit „Klug entscheiden“ erreichen? (2020) (0)
- Histon-Deazetylase-Inhibitoren als Wirkstoffe in chronischen intestinalen Entzündungen und deren Einfluss auf die Th-Zell-Polarisierung (2009) (0)
- New Treatment Options for Proctitis. A Prospective, Double Blind, Randomized Study of Budesonide Suppositories (2017) (0)
- Geschlechtsspezifische Unterschiede bei chronisch-entzündlichen Darmerkrankungen (2019) (0)
- FRI0323 THE PRESENCE OF SPONDYLOARTHRITIS IS ASSOCIATED WITH HIGHER CLINICAL DISEASE ACTIVITY IN PATIENTS WITH EARLY CROHN’S DISEASE: RESULTS OF A PROSPECTIVE COHORT STUDY (2020) (0)
- Contents Vol. 94, 2016 (2017) (0)
- Bakterienstämme, die im Rahmen der Dysbiose bei CED verändert vorkommen, zeigen unterschiedliche Effekte auf humane Monozyten und Makrophagen in vitro (2014) (0)
- Sa1897 – HDAC Inhibitors Drive TGF-β1-Mediated Strengthening and Regeneration of the Intestinal Epithelial Barrier During Inflammation (2019) (0)
- Kompetenznetz Darmerkrankungen (2016) (0)
- Effektorphase der intestinalen Immunantwort: Regulation durch Interleukin-18und Leptin: intestinale Immunantwort (2006) (0)
- [Multiple muscle abscesses in a Tibetan woman]. (2000) (0)
- DOP13 Immune profiling of adipose tissue in murine models of inflammatory bowel disease (IBD) (2019) (0)
- Molekulare Prognosefaktoren für Patienten mit Adenokarzinomen des Ösophagus und des Magens im Stadium T1/2N0 (2014) (0)
- Molekulare Diagnostik der infektiösen Gastroenteritis (2020) (0)
- Der Transkriptionsfaktor NF-κB: ein Angriffspunkt für die therapeutische Wirkung von Histon-Deacetylaseinhibitoren in Modellen Entzündungs-assoziierter Kolonkarzinogenese (2007) (0)
- Differenzierte empirische Therapie der akuten Cholangitis unter Berücksichtigung von Erregerspektrum, lokaler Resistenzlage und individueller Patientenfaktoren (2019) (0)
- Europaweite Studie zur Leberbeteiligung beim Alpha1-Antitrypsin-Mangel offenbart die Leberfibrose und -steatose in Erwachsenen mit dem homozygoten PiZZ-Genotyp (2017) (0)
- Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort (2022) (0)
- Darstellung einer verminderten T-Zellrezeptorvariabilität bei refraktärer Zöliakie Typ II mittels Next Generation Sequencing (2014) (0)
- DER MENSCH IST NICHT NUR ARBEITSMASCHINE (1998) (0)
- FOXM1 as chemo-sensitizing target in neuroendocrine lung tumors (2016) (0)
- Crohn Colits und Dünndarm-Crohn – auch mesenteriales Fettgewebe weist auf unterschiedliche Erkrankungen hin (2016) (0)
- Leptin-deficient (Ob/Ob) mice are resistant to experimental colitis: Role of pro-inflammatory cytokines (2001) (0)
- Inflammations-assoziierte Karzinogenese und Chromosomale Instabilität: Validierung eines murinen Modells Colitis-assoziierter Karzinome (2010) (0)
- Schmerzreduktion bei Patienten mit chronisch entzündlicher Darmerkrankung durch transkranielle Gleichstromstimulation (2015) (0)
- [Erratum to: Ustekinumab for the treatment of Crohn's disease. UNITI-IM-UNITI]. (2017) (0)
- Die Proktokolektomie bei Colitis Ulcerosa – Ist ein mehrzeitiges Vorgehen bei Immunsuppression gerechtfertigt? (2011) (0)
- Neugeborenes mit Extremitätenduplikationen und weiteren Fehlbildungen im Sinne eines „Dysorganization-like“ Syndroms* (2010) (0)
- Su1962 Lipid Metabolism Modulates Regulatory Phenotype of MDS (2016) (0)
- Expression funktioneller TLR und NOD Proteine in humanen mesenterialen Präadipozyten (2008) (0)
- Histon-Deacetylaseinhibitoren zeigen anti-inflammatorische und anti-proliferative Wirkungen in verschiedenen Modellen experimenteller Kolitis (2005) (0)
- Regulation der Makrophagenaktivität durch die Histondeacetylase 5 – Ein neuer Ansatz zur Therapie chronisch entzündlicher Darmerkrankungen? (2013) (0)
- Biosimilars in der Behandlung chronisch entzündlicher Darmerkrankungen (2016) (0)
- Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides (2016) (0)
- Activin als positiver prognostischer Marker bei Magenkarzinomen (2019) (0)
- 496: OSTEOPONTIN A POTENTIAL PROMOTER OF COLITIS ASSOCIATED CARCINOMA IN CHRONIC COLITIS – A MOLECULAR STUDY IN HUMANS (2022) (0)
- S822 Fatigue Improvement Correlates With Reductions in Work Productivity Impairment and Related Indirect Cost in Patients With Crohn’s Disease: Post Hoc Analysis of Phase 3 Rizankizumab Induction Trials (2022) (0)
- Tu1479: NORMALISATION OF BIOMARKERS AND IMPROVEMENT IN CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE TREATED WITH RISANKIZUMAB IN THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES (2022) (0)
- Die Adipozytenfunktion im mesenterialen Fettgewebe hängt vom angeborenen Immunsystem ab (2018) (0)
- Coronavirus-Pandemie: Wirksame Regeln für Herbst und Winter aufstellen : 6. Ad-hoc-Stellungnahme - 23. September 2020 (2020) (0)
- Eine neue Dynamik in den Therapiestrategien der chronisch-entzündlichen Darmerkrankungen (2019) (0)
- Analysis of circulating nutritional antigen-specific T-cells in celiac disease and inflammatory bowel disease (2020) (0)
- Titel Page / Editorial Board / Contents Band 25, Heft 4, Dezember 2009 (2009) (0)
- Inzidenz und Schweregrad einer Azathioprin-induzierten akuten Pankreatitis bei Patienten mit chronisch entzündlichen Darmerkrankungen (2015) (0)
- P501 Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02). (2017) (0)
- Rezidivierende Pankreatitiden bei einer 43-jährigen Patientin mit High-Output Stoma (2021) (0)
- P031 Impact of nutritional antigens in inflammatory bowel disease patients (2019) (0)
- A systematic review (2019) (0)
- Veränderung der Integrin-Expression unter Therapie mit Vedolizumab bei Patienten mit chronisch entzündlichen Darmerkrankungen (2019) (0)
- Die TNF-Expression von Monozyten ist ein prädiktiver Parameter für ein Therapieansprechen auf Infliximab (2017) (0)
- Leptin als Modulator der Aktivität polarisierter Makrophagen – ein übersehener Effektor im hypertrophierenden Fettgewebe bei Morbus Crohn? (2009) (0)
- Einfluss von Darmbakterien auf die Barrierefunktion und Immunzellzusammensetzung im Darm (2015) (0)
- Polarisation und Funktion von Makrophagen-Subtypen – Relevanz für CED? (2013) (0)
- Kurzfassung der aktualisierten S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und des Kompetenznetzes Darmerkrankungen zur Diagnostik und Behandlung des Morbus Crohn (2009) (0)
- M2 Makrophagen in hypertrophierten mesenterialen Fett bei Morbus Crohn – Regulatoren der T-Zell Inflammation im benachbarten Darm? (2011) (0)
- Correction: Complication rates of direct puncture and pull-through techniques for percutaneous endoscopic gastrostomy: Results from a large multicenter cohort (2022) (0)
- Chronisch-entzündliche Darmerkrankungen (2014) (0)
- Polarisierte Makrophagen verändern ihren Phänotyp entsprechend des lokalen Zytokin-Milieus (2014) (0)
- M1-Makrophagen in der Lamina propria: Zerstörung der intestinalen Barriere bei CED-Patienten? (2012) (0)
- Britta Siegmund and Markus van der Giet in Critically Ill Patients Use of a Nutrition Support Protocol to Increase Enteral Nutrition Delivery (2014) (0)
- Aktuelle Therapie des Morbus Crohn (2014) (0)
- Mo1998 the Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Ameliorate Experimental Colitis in Mice (2012) (0)
- Zöliakie und Darmlymphome (2015) (0)
- Arzneimitteltherapie in der Gastroenterologie – Stand und Perspektiven (2021) (0)
- P061 Immune cell infiltrations of myenteric plexus in IBD – characterization and implications (2021) (0)
- Inhibition der Histon-Deacetylierung: Protektion in experimenteller Colitis (2004) (0)
- Interleukin-13 induziert Polaritätsdefekte im intestinalen Epithel (2015) (0)
- Tumor-Surveillance bei chronisch entzündlichen Darmerkrankungen (2019) (0)
- Induction of M2 Macrophages via Inhibition of Histone Deacetylases (2011) (0)
- Decreased NK cell functions from obese F344 rats can be altered after transfusion in lean littermates (2008) (0)
- International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients (2023) (0)
- Anschriften der Herausgeber und Autoren (2021) (0)
- 6 Chronisch entzündliche Darmerkrankungen: Morbus Crohn, Colitis ulcerosa (2019) (0)
- Die Grenzen des G-DRG-Systems bei der Abbildung von Komplexität in der Universitätsmedizin (2020) (0)
- Frühe Ansprechanalyse auf Chemotherapie durch RNA Sequenzierung bei Magenkarzinomen (2015) (0)
- Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL‐10 (2023) (0)
- Inflammasom-Aktivierung in mesenterialen Fettzellen – Relevanz für Morbus Crohn? (2011) (0)
- Vedolizumab in der Therapie chronisch-entzündlicher Darmerkrankungen: Klinische Wirksamkeit und Sicherheit nach 12 Monaten (2016) (0)
- W1190 Expression of Functional TLR and NOD Proteins in Human Mesenteric Preadipocytes (2008) (0)
- Inflammatory Bowel Diseases: Current Medical and Surgical Therapy (2015) (0)
- Die Rolle von HDAC7 in intestinalen Epithelzellen und CED (2018) (0)
- DGVS Jahresrückblick 2021 (2021) (0)
- Dual inhibition of PI3K and mTORC1/C2 by PKI-587 (PF-05212384) as a promising therapeutic option for pulmonary neuroendocrine tumor disease (2016) (0)
- P015 Differential expression in colitis-associated cancer compared to Crohn′s disease and ulcerative colitis (0)
- Frequenz familiärer Merkmale bei Adenokarzinomen des gastroösophagealen Übergangs und Magens in Berlin (EpihiB-Studie) (2018) (0)
- Autoren (2019) (0)
- Erregerspektrum, Resistenzanalyse und Risikofaktoren für multiresistente Erreger bei akuter eitriger Cholangitis (2016) (0)
- Vergleichbare Expression von Pattern-recognition Rezeptoren in Präadipozyten und Makrophagen: Fettgewebe als erste Verteidigungsbarriere bei intestinalen Entzündungen? (2009) (0)
- Adipozyten und Präadipozyten: Proinflammatorische Zellen im mesenterialen Fettgewebe (2006) (0)
- Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten (2020) (0)
- Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: Phase II Randomized Controlled Clinical Trial. (2023) (0)
- 10. Medikamentöse Therapie der Colitis ulcerosa (2018) (0)
- M2-Chemotaxis- Auswirkung auf die T-Zellpopulation im Creeping Fat (2014) (0)
- Die Rolle von Fettsäuren bei der Entstehung des funktionellen Phänotyps von MDSC (2015) (0)
- P031 Induction of an M2 macrophage phenotype by the HDAC inhibitor ITF2357 (2012) (0)
- Subject Index Vol. 34, Suppl. 1, 2016 (2016) (0)
- P003 HDAC7 Controls Differentiation and Regeneration in the Intestinal Epithelium (2021) (0)
- P115 The influence of maternal IBD on childbirth and further development of children (2014) (0)
- Prospektive epidemiologische Registerstudie zur Erfassung hereditärer Merkmale von Patienten mit Adenokarzinomen des gastroösophagealen Übergangs und Magens in Berlin (2016) (0)
- P108 Differential expression in colitis-associated cancer compared with Crohn’s disease and ulcerative colitis (2018) (0)
- P045 Macrophage subtypes disrupt the epithelium via deregulated tight junctions and induction of apoptosis (2014) (0)
- Expression und Funktionalität von NOD1, NOD2 und NALP3 in mesenterialen Präadipozyten (2006) (0)
- Leptin: Ein wichtiger Mediator bei der intestinalen Entzündung–Rolle von Adipozyten und Präadipozyten im angeborenen Immunsystem (2005) (0)
- Multizentrische Studie zur Leberbeteiligung beim Alpha1-Antitrypsin-Mangel (2016) (0)
- „Interferon regulatory factor-1“ als protektiver Mediator in der intestinalen Entzündung (2015) (0)
- Epigenetische Modulation als therapeutischer Ansatz im experimentellen Model für inflammations-assoziierte Tumorgenese (2006) (0)
- Geringe Lymphozyteninfiltration als negativer prognostischer Marker bei frühen Adenokarzinomen des Magens und gastroösophagealen Übergangs (2016) (0)
- Leptin: Ein unspezifischer T-Zellstimulus in der intestinalen Entzündung (2004) (0)
- Fettgewebs-T-Zellen mit „Gut-homing“-Potential könnten die intestinale Barrierefunktion bei Morbus Crohn und Adipositas permagna beeinflussen (2016) (0)
- Die vollständige histopathologische Remission ist ein wichtiger prognostischer Parameter für perioperativ mit ECF behandelte Patienten mit lokal fortgeschrittenem Karzinomen des Magens und gastroösophagealen Übergangs (2014) (0)
- DGVS Jahresrückblick 2021 (2021) (0)
- Pathogenese chronisch-entzündlicher Darmerkrankungen (2020) (0)
- Schiene, verbindungsrahmen und rollfuss eines schienensystems für schweisstische (2014) (0)
- Immunbiologie chronisch-entzündlicher Darmerkrankungen (2006) (0)
- Ustekinumab als Therapeutikum bei Morbus Crohn (2017) (0)
- Sensorik und Lebensmitteltechnologie: Salzreduktion - Möglichkeiten und Grenzen (2013) (0)
- Morbus Crohn (2019) (0)
- Hohe Lymphozyteninfiltration als positiver prognostischer Marker bei Adenokarzinomen des Magens und gastroösophagealen Übergangs (2017) (0)
- Wirkung von Histon-Deacetylase-Inhibitoren auf CD4-T-Zellen in chronischen intestinalen Entzündungen (2008) (0)
- Induktion des M2-Phänotyps der „Wundheilungsmakrophagen“ durch den HDAC-Inhibitor ITF2357 (2010) (0)
- Personalia – Der Vorstand stellt sich vor (2017) (0)
- Das Leitlinienprogramm 3.01 der DGVS 2022 (2022) (0)
- Murine Makrophagen zeigen einen M2-Phänotyp und ein verändertes IL-6-Signaling nach Behandlung mit dem HDAC-Inhibitor Givinostat (ITF2357) (2012) (0)
- P501 High TNF-production of CD14+ cells and short disease duration are independent predictive factors for response to Infliximab treatment (2019) (0)
- Translokation von Tropheryma whipplei über das Darmepithel (2014) (0)
- F 8 – Dünndarmstörungen als Teilaspekt systemischer Erkrankungen (2007) (0)
- Vom besseren Verständnis tumor-assoziierter Signalwege und der „Übersetzung“ in innovative Therapeutika: präklinische Ergebnisse zur dualen PI3K/mTOR-Inhibition bei gastroenteropankreatischen neuroendokrinen Neoplasien (2014) (0)
- Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis? (2020) (0)
- Subzelluläre Lokalisation von MICA in Abhängigkeit vom MICA-Genotyp bei Zöliakie (2016) (0)
- 123 PATIENT AND PHYSICIAN PERSPECTIVES ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: ROLE OF STEROIDS IN THE CONTEXT OF BIOLOGIC THERAPY (2020) (0)
- OP0031 SHARED AND DISTINCT GUT MICROBIOME SIGNATURES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND ITS RELATED IMMUNE-MEDIATED DISEASES (2021) (0)
- Evaluation von Gründen für eine verzögerte Diagnosestellung von chronisch entzündlichen Darmerkrankungen (2016) (0)
- Cardiac sarcoidosis presenting with complex conduction abnormalities as the first manifestation of widespread systemic sarcoidosis: a case report (2023) (0)
- Transitionsmedizin (2018) (0)
- Der spezifische Typ-4 Phosphodiesterase Inhibitor Roflumilast führt zu einer Verbesserung der AKUTEN experimentellen Kolitis in der Maus (2005) (0)
- TLR-vermittelte Zytokinproduktion durch Zellen des Fettgewebes – ein Beitrag zur chronischen Entzündung? (2007) (0)
- Supplementary Material for: Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease (2016) (0)
- Pathophysiology of perianal fistulising disease (2015) (0)
- P039 Reprogramming of intestinal epithelial cells by interleukin-22 (2013) (0)
- CapsoCam SV-1 versus PillCam SB 3: Prospektive randomisierte Multicenter-Studie zum Vergleich beider Dünnarmkapseln bei obskurer gastrointestinaler Blutung (2017) (0)
- Leptin – ein Regulator der Th1/Th2 Balance (bei Morbus Crohn)? (2008) (0)
- European Cohort Reveals Liver Fibrosis and Steatosis in Adults with Homozygous Alpha1-antitrypsin Deficiency (PiZZ Genotype) (2017) (0)
- Indirekter Vergleich von Vedolizumab und Adalimumab für Biologika-naive Patienten mit Colitis ulcerosa: Ein systematischer Review und Metaanalyse (2018) (0)
- Adipokine des mesenterialen Fettgewebes als Modulatoren des Immunphänotyps lokaler Makrophagen (2010) (0)
- Akute infektiöse Enteritiden bei Erwachsenen (2019) (0)
- Aktivierung mesenterialer Präadipozyten durch NOD1, NOD2 und NALP3 (2007) (0)
- Sachwortverzeichnis Band 25, 2009 (2009) (0)
- P306 Analysis of psychological and psychosocial impairment factors in patients with inflammatory bowel disease (2013) (0)
- Erratum zu: Ustekinumab als Therapeutikum bei Morbus Crohn. UNITI-IM-UNITI (2017) (0)
- HDAC als funktionelle Regulatoren der intestinalen Barriere in der chronisch entzündlichen Darmerkrankung (2016) (0)
- Tu1776 - Modulation of Immune Cell Composition, Function and Metabolism by Recombinant Leptin in a Patient with Acquired Generalized Lipodystrophy and Combined Crohn's Disease (2018) (0)
- Infection and Differentiation during Gut Inflammation Regulates Murine Th17 NSB k I (0)
- Medullärer Phänotyp als negativer prognostischer Marker bei frühen Adenokarzinomen des Magens und des gastroösophagealen Übergangs (2015) (0)
- Transfer colitis in Rag1-/-- mice enhances hepatic MMP–9 expression (2012) (0)
- Hinweise für Autoren · Guidelines for Authors (2009) (0)
- Inflammation in the Intestinal Tract: Pathogenesis and Treatment: Falk Symposium 169, Kiev, May 2009 (2009) (0)
- Nachruf auf Prof. Dr. Martin Zeitz (1950–2013) (2014) (0)
- Tu1646 HDAC Dependent Regulation of the IL-6/STAT3 Pathway During T Helper Cells Activation (2013) (0)
- Tu1854 - Microbiota-Trained Barrier Function is Essential for the Differentiation and Function of Intestinal Macrophages (2018) (0)
- Inhalt Band 25, 2009 (2009) (0)
- Animal Models of IBD 2 (2009) (0)
- Arzneimitteltherapie in der Gastroenterologie – Stand und Perspektiven (2021) (0)
- Die Bedeutung von Nahrungsproteinen für mukosale Homöostase und Entzündung (2017) (0)
- Subject Index Vol. 33, Suppl. 1, 2015 (2015) (0)
- Einsatz von EndoClotTM bei gastrointestinalen Blutungen: Ergebnisse einer prospektiven Multi-Center Pilotstudie (2015) (0)
- 887: WITHDRAWAL OF INFLIXIMAB OR ANTI-METABOLITE THERAPY IN CROHN'S DISEASE PATIENTS IN SUSTAINED REMISSION ON COMBINATION THERAPY: A RANDOMIZED UNBLINDED CONTROLLED TRIAL (SPARE) (2022) (0)
- Effektorphase der intestinalen Immunantwort: Regulation durch Interleukin-18 und Leptin (2006) (0)
- Mo1827 HDAC 5 As a Promising Target for the Treatment of Inflammatory Bowel Disease (2015) (0)
- Fehlaromen als Indikatoren für mikrobiellen Verderb von Lebensmitteln (2012) (0)
- Der Duft von alten Apfelsorten (2017) (0)
- Geruchsschwellenwerte mikrobiell hervorgerufener Fehlaromen in Apfelsaft (2006) (0)
- P055 Factors from human mesenteric adipose tissue control intestinal stem cell differentiation and proliferation in vitro (2022) (0)
- Sa1773 Reduced T-Cell Receptor Variability in Refractory Celiac Disease Type II As Revealed by Next Generation Sequencing (2015) (0)
- Quantifizierung aromarelevanter Holunderblüteninhaltsstoffe mittels unterschiedlicher gaschromatographischer Methoden (2012) (0)
- Der Einsatz von sensorischen und instrumenteller Aromastoff-Analytik zur Unterstützung der steirischen Obstwirtschaft (2017) (0)
- Untersuchung und Optimierung der Aromaeigenschaften eines Convenience-Food Produktes (1997) (0)
- Die elektronische Nase - Eine neue Technik in der Lebensmittelanalytik (1998) (0)
- 2,5-Dimethyl-4-Hydroxy-3(2H)-furanon (Furaneol(R)) als mehrdimensionale Schlüsselkomponente in Erdbeeren (2010) (0)
- Der Geruch der Jugend? Eine Pilotstudie des Sensorik Netzwerks Österreich (2016) (0)
- Chronische Diarrhö (2021) (0)
- Wenn es im Pelletlager stinkt (2015) (0)
- Charakterisierung flüchtiger Aromaverbindungen bei der Reifung von Mangos (2018) (0)
- Leptin and Gastrointestinal Inflammation (2007) (0)
- Von der Zellkultur zum Herzen in vivo Entwicklung eines neuen Weges zur Myokardzellprotektion (1993) (0)
- Einfluss der klimatischen Bedingungen auf die Aromastoffe von sortenreinem Apfelsaft (2015) (0)
- Die Verarbeitung von Holunderblüten als kritischer Schritt in Hinblick auf die sensorische Qualität von Holunderblütensirup (2014) (0)
- Tu1839 - The HDAC Inhibitors Givinostat and Vorinostat Promote Intestinal Epithelial Regeneration via Autocrine Cytokine Signaling in Inflammation (2018) (0)
- P101 Interleukin-13 induces polarity defects in the intestinal epithelia. (2017) (0)
- Das Aroma von lebensmitteln betrachtet aus verschiedenen Blickwinkeln (2018) (0)
- Klassifizierung von Holunderblüten basierend auf ihren Aromakomponenten (2010) (0)
- Die Bildung von Maillard Produkten bei der Herstellung von Hanföl (2018) (0)
- Alte steirische Apfelsorten - die Sorte macht das Aroma (2018) (0)
- Prospektive Multi-Center-Studie zur Evaluation eines Point-of-Care-Tests (POCT) bei Zöliakie (2017) (0)
- Die Vielfalt des Duftes von alten Apfelsorten untersucht mittels instrumenteller und sensorischer Methoden (2014) (0)
- Vergleich des Blütenaromas verschiedener Holundersorten (sambucus nigra) mit verschiedenen Techniken der Aromastoffanalytik (2012) (0)
- Sensorische Charakterisierung von steirischen Apfelsorten aus dem Streuobstbau (2013) (0)
- Formula-fed and Clostridioides difficile infected neonatal piglets carry a highly diverse and abundant set of antimicrobial resistance genes (2020) (0)
- P085 Deep profiling of the circulating immune cell landscape in inflammatory bowel disease by mass cytometry (2020) (0)
- Pralnacasan improves experimental murine colitis JPET # 57059 1 The ICE inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and Th 1 T-cell activation (2003) (0)
- Pellets unter der Lupe: Vergleich von Holz- und Nicht-HolzPellets (2014) (0)
- Aromaextraktions Verdünnungsanalyse von gebratenem Lammfett (1995) (0)
- Die Bedeutung von Methylobakterien für die Aromabildung von Erdbeeren (2011) (0)
- [Quality management in the field of gastroenterology - Proposals of the Quality Commission of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) for Outpatient and Inpatient Quality Assurance]. (2021) (0)
- Su1580: MASS CYTOMETRY-BASED IMMUNE PROFILING OF HUMAN PEYER'S PATCHES IN INFLAMMATORY BOWEL DISEASE (2022) (0)
- M1938 Critical Comparison of Genomic Instability in Inflammation-Associated Colorectal Cancer of Man and Mice (2010) (0)
- Distal Fecal Wash: Intestinal Liquid Biopsy? (2023) (0)
- Sortendifferenzierung vom Holunderblüten mittels sensorischer Methoden (2011) (0)
- C3a, C4a and C5a plasma levels change after liver resection in correlation with a systemic chemokine response (2007) (0)
- CYTO 2018 award recipients (2018) (0)
- Charakterisierung der sensorischen Eigenschaften von ursprunggeschützten Lebensmitteln (2012) (0)
- Das Aroma von alten Streuobstsorten (2015) (0)
- S928 Effect of Etrasimod on Circulating Lymphocytes in Patients With Moderately to Severely Active Ulcerative Colitis: Data From the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials (2022) (0)
- Improving treatment of patients with inflammatory bowel diseases: a controlled trial of a multifaceted intervention in two German cities (2019) (0)
- Increased motility and suppression of ex vivo-expanded regulatory T cells designed for adoptive transfer therapy in ulcerative colitis. (2023) (0)
- Sensorische Charakterisierung von sortenreinen Apfesäften aus steirischen Streuobstsorten (2014) (0)
- Glutensensitive Enteropathie, Zöliakie (2021) (0)
- Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing (2023) (0)
- P494 Monocytic TNF production predicts response to infliximab treatment in Crohn’s disease but not ulcerative colitis (2018) (0)
- Mikrobielle Kontamination als Ursache für Fehlgerüche bei der Lagerung von Holzpellets (2015) (0)
- Die Kombination instrumenteller und sensorischer Methoden zur Identifizierung aromaaktiver Verbindungen in Fleisch (1996) (0)
- 738 Histone Deacetylases As Targets in Chronic Intestinal Inflammation (2008) (0)
- Das Aroma der Apfelsorte Ilzer Rose in Abhängigkeit des Reifegrads (2018) (0)
- 2,5-Dimethyl-4-hydroxy-3(2H)-furanon (Furaneol®) als mehrdimensionaler Schlüsselaromakomponente in Erdbeeren (2010) (0)
- Die Rolle von Methylobakterien bei der Aromaproduktion in Erdbeeren (2010) (0)
- T1215 Adipokines and Immunity. On the Interplay Between Adipose Tissue and T Lymphocytes (2008) (0)
- [Ulcerative colitis? Guidelines 2004]. (2005) (0)
- Differenzierung von Holzpellets anhand ihrer flüchtigen Verbindungen (2012) (0)
- Sa1736 Macrophage Subtypes Disrupt the Epithelium via Deregulated Tight Junctions and Induction of Apoptosis (2014) (0)
- Analyse von Holzpellets: Duft oder Fehlaroma? (2015) (0)
- DOP001 Epithelial polarity is disrupted by interleukin-22 (2014) (0)
- Charakterisierung von Aroma und Fehlaroma in Holzpellets (2014) (0)
- Bestimmung von Furaneol und Mesifuran in Erdbeeren (2008) (0)
- Sensorische und analytische Charakterisierung von „Ilzer Rose“- eine typische alt-steirische Streuobstapfelsorte (2016) (0)
- Aromakomponenten in Holunderblüten (2011) (0)
- P060 The pharmacologic inhibition of store-operated calcium entry pathway in inflammatory bowel disease (2020) (0)
- Die Komplexität des Erdbeeraromas in der sensorischen Prüfung (2008) (0)
- Borreliose (2021) (0)
- Chronisch entzündliche Darmerkrankungen: State of the Art (2014) (0)
- Update of the Inhibitor-Immunology-Study (2007) (0)
- Von Willebrand Factor antigen and age explain variation in baseline FVIII: C among nonsevere hemophilia A patients with the same F8 genotype (Arg593Cys and Asn618Ser) (2014) (0)
- Acute reperfusion injury of myocardium (1997) (0)
- [Recurrent pancreatitis in a 43-year-old patient with high-output stoma]. (2021) (0)
- 98 Association between primary brain tumours and specific IgE levels, measured in participants of the EPIC cohort study (2010) (0)
- Tu1959 Disruption of the Intestinal Barrier Through M1 Macrophages - Relevance for IBD? (2012) (0)
- Immunopathology and Infectious Diseases Manifestation of Spontaneous and Early Autoimmune Gastritis in CCR 7-Deficient Mice (2011) (0)
- W1787 Altered Local Adipokine Production in Crohn's Disease Mesenteric Fat – A Regulator of Macrophage Activity? (2010) (0)
- [Ustekinumab for the treatment of Crohn's disease : UNITI-IM-UNITI]. (2017) (0)
- DOP056 Pathophysiology of perianal fistulising disease. (2017) (0)
- Analysis of Circulating Food Antigen-Specific T-Cells in Celiac Disease and Inflammatory Bowel Disease (2023) (0)
- Selective Inhibition of PI3Kalpha (BYL719) - Promising Therapeutic Option for Neuroendocrine Tumors? (2016) (0)
- ROLE OF LEPTIN IN ACUTE PANCREATITIS INDUCED BY IL‐12 AND IL‐18: 140 (2004) (0)
- S766 The Effect of Mirikizumab on Fecal Calprotectin and C-Reactive Protein in Phase 3 Studies of Patients With Moderately-to-Severely Active Ulcerative Colitis (2022) (0)
- Inflammatory bowel disease (2020) (0)
- THROMBOSIS AND HEMOSTASIS Factor VIII gene ( F 8 ) mutation and risk of inhibitor development in nonsevere hemophilia A (2013) (0)
- Sa1860 Adipose Tissue T-Cells In Creeping Fat Might Impact Intestinal Inflammation (2016) (0)
- 913 HDAC Dependent Regulation of the IL-6/STAT3 Pathway Provides a Potential Therapeutic Target for Intestinal Inflammation (2010) (0)
- P511 Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01). (2017) (0)
- Clinical presentation of inhibitor development in non-severe hemophilia A: Half of patients have high titer inhibitors and present with bleeding complications (2014) (0)
- Deciphering Cellular Networks in Creeping Fat. (2023) (0)
- Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg (1990) (0)
- P111 Elucidation of inflammatory infiltration of myenteric plexus in IBD (2020) (0)
- MACC1 in esophageal and gastric adenocarcinomas (AGE/S): An aggressive but drugable oncogene (2018) (0)
- Energy and Cation Control in the Reoxygenated Myocardial Cell (1996) (0)
- 1094 The Impact of HDAC Inhibition On CD4+ T Cells in Chronic Intestinal Inflammation (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Britta Siegmund?
Britta Siegmund is affiliated with the following schools:
